LakeShore Biopharma Co., Ltd Working Capital to Net Assets Ratio
LakeShore Biopharma Co., Ltd working capital to net assets ratio. LakeShore Biopharma Co., Ltd (LSB) has a Working Capital to Net Assets ratio of 3.5% as of June 2025. Working capital of $17.47 Million (current assets of $842.22 Million minus current liabilities of $824.75 Million) is measured against net assets of $499.75 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check LakeShore Biopharma Co., Ltd (LSB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of LakeShore Biopharma Co., Ltd (2021–2025)
Working capital to net assets ratio of LakeShore Biopharma Co., Ltd from 2021 to 2025. This chart shows how LakeShore Biopharma Co., Ltd's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the ratio stands at 3.5%, reflecting working capital of $17.47 Million against net assets of $499.75 Million USD. See defensive interval ratio of LakeShore Biopharma Co., Ltd to measure how many days the company can operate on defensive assets alone.
LakeShore Biopharma Co., Ltd Working Capital to Net Assets Ratio by Year (2021–2025)
LakeShore Biopharma Co., Ltd working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for LakeShore Biopharma Co., Ltd from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LakeShore Biopharma Co., Ltd assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.5% | $17.47 Million | $499.75 Million | $842.22 Million | $824.75 Million | ▼ -13.8 pp |
| 2024 | 17.2% | $100.94 Million | $585.21 Million | $903.17 Million | $802.23 Million | ▼ -34.5 pp |
| 2023 | 51.8% | $377.22 Million | $728.45 Million | $1.04 Billion | $658.76 Million | ▼ -371.4 pp |
| 2022 | 423.2% | $764.62 Million | $180.68 Million | $764.76 Million | $142.63K | ▼ -1816480.4 pp |
| 2021 | 1816903.6% | $388.16 Million | $21.36K | $733.20 Million | $345.04 Million | — |